A01K 2207/15
Humanized animals
A01K2207/15 (Humanized animals) appears on 1,165 US grants and 1,666 published applications in this corpus.
Search patents in A01K- Granted patents
- 1,165
- Published applications
- 1,666
- Assignees
- 682
- Inventors
- 2,681
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 5 | 0 |
| 1996 | 19 | 0 |
| 1997 | 36 | 0 |
| 1998 | 57 | 0 |
| 1999 | 50 | 0 |
| 2000 | 55 | 0 |
| 2001 | 50 | 7 |
| 2002 | 40 | 68 |
| 2003 | 46 | 110 |
| 2004 | 23 | 82 |
| 2005 | 22 | 58 |
| 2006 | 41 | 57 |
| 2007 | 30 | 44 |
| 2008 | 31 | 34 |
| 2009 | 26 | 53 |
| 2010 | 28 | 39 |
| 2011 | 19 | 67 |
| 2012 | 20 | 44 |
| 2013 | 16 | 47 |
| 2014 | 30 | 64 |
| 2015 | 43 | 80 |
| 2016 | 44 | 74 |
| 2017 | 41 | 83 |
| 2018 | 48 | 69 |
| 2019 | 51 | 83 |
| 2020 | 45 | 81 |
| 2021 | 53 | 75 |
| 2022 | 46 | 62 |
| 2023 | 38 | 73 |
| 2024 | 38 | 90 |
| 2025 | 38 | 79 |
| 2026 | 26 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Non-human animals having humanized Fc-gamma receptors29 Sep 2026US 12,745,761 B2Regeneron Pharmaceuticals, Inc.
- Genetically modified non-human animal with human or chimeric TFR122 Sep 2026US 12,740,550 B2Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Methods of treating mitochondrial disorders1 Sep 2026US 12,723,062 B2The Regents of the University of California
- Single chain VH and heavy chain antibodies25 Aug 2026US 12,715,906 B2Trianni, Inc.
- Non-human animals comprising a humanized ACE2 locus11 Aug 2026US 12,702,122 B2Regeneron Pharmaceuticals, Inc.
- Humanized ace2-expressing transgenic mouse susceptible to sars-cov-2 virus infection and method for producing same8 Oct 2026US 2026/0305587 A1Seoul National University R&Db Foundation
- Methods and compositions for insertion of antibody coding sequences into a safe harbor locus1 Oct 2026US 2026/0297613 A1Regeneron Pharmaceuticals, Inc.
- Production of antibodies by modification of an autonomous heavy chain variable domain by gene conversion3 Sep 2026US 2026/0256123 A1Crystal Bioscience Inc.
- Methods and materials for treating gastrointestinal disorders27 Aug 2026US 2026/0248863 A1Mayo Foundation for Medical Education and Research
- Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use Thereof27 Aug 2026US 2026/0248964 A1Intellia Therapeutics, Inc.
Most cited
By later US patents
- Ransgenic non-human animals for producing heterologous antibodies1,941US 5,545,806 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies of various isotypes1,748US 5,569,825 AGenPharm International, Inc. · 1996
- Transgenic non-human animals capable of producing heterologous antibodies1,680US 5,633,425 AGenPharm International, Inc. · 1997
- Transgenic non-human animals for producing heterologous antibodies1,604US 5,625,126 AGenPharm International, Inc. · 1997
- Production of antibodies from transgenic animals1,567US 5,545,807 AMedical Research Council · 1996